Amgen Inc (HKSE:04332)
HK$ 1761 0 (0%) Market Cap: 1.18 Til Enterprise Value: 1.58 Til PE Ratio: 36.22 PB Ratio: 20.20 GF Score: 92/100

Amgen Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Transcript

Jan 09, 2020 / 09:00PM GMT
Release Date Price: HK$1000
Terence C. Flynn
Goldman Sachs Group Inc., Research Division - MD

Well, thanks so much, Bob and Peter, for joining us. I'm Terence Flynn, the biopharma analyst here at Goldman Sachs. And this afternoon to close out the CEO conference, we're very pleased to have Amgen joining us via video conference. Thank you to Bob and Peter. Bob Bradway is Chairman and CEO; Peter Griffith is the new CFO of the company, but thank you both for joining us today.

First, I'm going to turn it over to Bob to make some opening remarks to kick it off, and then we'll go through a number of questions. But thanks, again, guys.

Robert A. Bradway
Amgen Inc. - Chairman, CEO & President

Well, thanks for having us, Terence. I hope your event is going well. I'll just point out that Arvind is also here with us in the room. So we're delighted to be here and to be included in your conference.

I'll be brief, because I know it's getting late in the day for you on your end. But let me just start by saying that we're feeling confident about the outlook for 2020. And we are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot